Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies-Reference-Cited by-同舟云学术

Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies

Published:2015-09-10 Issue:3 Volume:138 Page:689-697
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Charkiewicz Radoslaw¹,Pilz Lothar¹²,Sulewska Anetta¹,Kozlowski Miroslaw³,Niklinska Wieslawa⁴,Moniuszko Marcin⁵,Reszec Joanna⁶,Manegold Christian¹²,Niklinski Jacek¹

Affiliation:

1. Department of Clinical Molecular Biology; Medical University of Bialystok; Bialystok Poland

2. Medical Faculty Mannheim; Heidelberg University; Mannheim Germany

3. Department of Thoracic Surgery; Medical University of Bialystok; Bialystok Poland

4. Department of Histology and Embryology; Medical University of Bialystok; Bialystok Poland

5. Department of Regenerative Medicine and Immune Regulation; Medical University of Bialystok; Bialystok Poland

6. Department of Medical Pathomorphology; Medical University of Bialystok; Bialystok Poland

Funder

National Science Centre (NCN)

Medical University of Bialystok

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.29816/fullpdf

Reference38 articles.

1. Treatment algorithm in 2014 for advanced non-small cell lung cancer: therapy selection by tumour histology and molecular biology;Manegold;Adv Med Sci,2014

2. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013

3. New monoallelic combination of KRAS gene mutations in codons 12 and 13 in the lung adenocarcinoma;Charkiewicz;Adv Med Sci,2013

4. P63 differentiates subtypes of nonsmall cell carcinomas of lung in cytologic samples: implications in treatment selection;Jorda;Cancer Cytopathol,2009

5. Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review;Field;J Natl Cancer Inst,2004

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Six-Gene Signature for Differential Diagnosis and Therapeutic Decisions in Non-Small-Cell Lung Cancer—A Validation Study;International Journal of Molecular Sciences;2024-03-23

2. Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer;Cancers;2023-10-10

3. miRNA-Seq Tissue Diagnostic Signature: A Novel Model for NSCLC Subtyping;International Journal of Molecular Sciences;2023-08-28

4. Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms;Cell Death & Disease;2020-11

5. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer;Biomedicine & Pharmacotherapy;2019-09